Vote Scores

Home / Companies / Merck & Co., Inc.

Company · votes reported on Form N-PXMRK · SEC company no. 310158

Merck & Co., Inc.

How funds and institutional managers reported voting their shares, year to 30 June 2026

Filers reporting
2,153year to 30 June 2026
Against management on pay
5.4%111 of 2,063 reporting filers
Same, by reported shares
3.7%shares reported on Form N-PX
Meetings on file
7across 3 seasons
91.5% for5.0% against3.5% other5.4% against management2,119 filers on say-on-pay

foragainstabstain, withhold or otheramber tick: the portion cast against management

For the year to 30 June 2026, 2,153 funds and managers listed Merck & Co., Inc. in their Form N-PX filings (4 meetings).

On the advisory vote on executive pay, 111 of the 2,063 filers that reported a position voted against management (5.4%), 1.2 percentage points below the median company on this site (6.6%). By reported shares the figure is 3.7% (median 2.9%). These are shares of the filers reporting on Form N-PX, not of all votes cast at the meeting.

Meetings

Meeting dateSeasonFilers reportingItemsAgainst management on pay
26 May 2026year to 30 June 20262,13175.4%
19 May 2026year to 30 June 2026410.0%
27 Mar 2026year to 30 June 20263133.3%
27 May 2025year to 30 June 20252,10199.2%
23 May 2025year to 30 June 2025510.0%
28 May 2024year to 30 June 20242,10484.9%
23 May 2024year to 30 June 2024410.0%

Meetings with 20 or more reporting filers have their own page with every item. Dates are as filers typed them; dates up to three days apart are treated as one meeting.

Say-on-pay: this company and the median

year to 30 June 2026Merck & Co., Inc.Median company
Reporting filers voting against management5.4%6.6%
Reported shares voted against management3.7%2.9%

Among filers reporting on Form N-PX. The median is over 3,799 companies with a say-on-pay item reported by 20 or more filers.

How the largest families voted

Meeting of 26 May 2026: say-on-pay and each shareholder proposal that could be told apart.

FamilySay-on-payProposal AProposal BProposal C
VanguardForAgainstAgainstAgainst
BlackRock and iSharesForAgainstAgainstAgainst
FidelityForAgainstAgainstAgainst
DimensionalForAgainstAgainstAgainst
State Street and SPDRForAgainstAgainstAgainst
American CenturyForAgainstAgainstAgainst
Franklin TempletonForAgainstAgainstAgainst
InvescoForAgainstAgainstAgainst
EquitableForAgainstAgainstAgainst
Charles SchwabForAgainstAgainstAgainst
Nuveen and TIAAForAgainstAgainstAgainst
ProShares and ProFundsForAgainstAgainstAgainst
John Hancock and ManulifeForAgainstAgainstAgainst
Morgan Stanley, Eaton Vance and CalvertForAgainstAgainstAgainst
J.P. MorganForAgainstAgainstAgainst
Goldman SachsForAgainstAgainstAgainst
WisdomTreeForAgainstAgainstAgainst
PGIM and PrudentialForAgainstAgainstAgainst
Jackson National fundsForAgainstAgainstAgainst
Northern Trust and FlexSharesForAgainstAgainstAgainst
SEIForAgainstAgainstAgainst
T. Rowe PriceForAgainstAgainstAgainst
ThriventForAgainstAgainstAgainst
Lincoln FinancialForAgainstAgainstAgainst
VoyaForAgainstAgainstAgainst
First TrustForAgainstAgainstAgainst
Russell InvestmentsForAgainstAgainstAgainst
NationwideForAgainstAgainstAgainst
Victory CapitalForAgainstAgainstAgainst
Brighthouse FundsForAgainst *Against *Against *
Guggenheim and RydexForAgainstAgainstAgainst
Columbia ThreadneedleForAgainstAgainstAgainst
BNY MellonForAgainstAgainstAgainst
PrincipalForAgainstAgainstAgainst
Capital Group and American FundsForAgainstAgainstAgainst
Pacific Life fundsForAgainstAgainstAgainst
Global XForAgainstAgainstAgainst
MFSForAgainstAgainstAgainst
TransamericaForAgainstAgainstAgainst
Federated HermesForAgainstAgainstAgainst
AllianceBernsteinForAgainstAgainstAgainst
Hartford FundsForAgainstAgainstAgainst
DWSForFor *AgainstAgainst
PIMCOForAgainstFor *Against
AllspringForAgainstAgainstAgainst
MassMutualForAgainstAgainstAgainst
Harbor FundsForAgainstAgainstAgainst
VirtusAbstain or withhold *For *AgainstAgainst
VanEckForAgainstAgainstAgainst
Macquarie and Delaware FundsForFor *AgainstAgainst
Janus HendersonForAgainstAgainstAgainst
Neuberger BermanForAgainstAgainstAgainst
American BeaconForAgainstFor *For *
Natixis and Loomis SaylesForAgainstAgainstAgainst
Lord AbbettSplit or no voteNo reportNo reportNo report
Cohen & SteersForNo reportNo reportNo report
Dodge & CoxForNo reportNo reportNo report
Harris Associates and OakmarkForAgainstAgainstAgainst
BairdForNo reportNo reportNo report
Artisan PartnersForAgainstAgainstAgainst

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

By season

SeasonFilers reportingAgainst management on pay, filersBy reported sharesSay-on-pay split
year to 30 June 20242,1124.9%withheld
year to 30 June 20252,1329.2%6.0%
year to 30 June 20262,1535.4%3.7%

Category mix

Share of the vote records reported for this company, by the category filers chose.

CategoryVote recordsShare
DIRECTOR ELECTIONS59,17264.2%
SECTION 14A SAY-ON-PAY VOTES12,85214.0%
OTHER SOCIAL ISSUES10,19211.1%
AUDIT-RELATED4,6735.1%
DIVERSITY, EQUITY, AND INCLUSION1,6871.8%
CORPORATE GOVERNANCE1,6831.8%
HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE1,6041.7%
COMPENSATION2480.3%

Questions

How did large funds vote at Merck & Co., Inc.?

For the year to 30 June 2026, 2,063 Form N-PX filers reported a say-on-pay vote at Merck & Co., Inc.; 111 voted against management (5.4%). The table on this page lists the position of each of the largest fund families on say-on-pay and on each shareholder proposal that could be told apart in the filings.

Were there shareholder proposals at Merck & Co., Inc.?

Filers reported 3 proposals from security holders that could be told apart in the year to 30 June 2026. Across them, 1.4% of reporting filers voted for at the median proposal.

Is this the meeting result?

No. The figures are shares of the funds and managers that file Form N-PX, and of the shares they reported. Holders that do not file the form (individuals, most foreign investors, insiders) are not included, so the split here can differ widely from the certified result, which Merck & Co., Inc. reports on Form 8-K.

Where does the data come from?

From Form N-PX filings on the SEC's EDGAR system, grouped by company. Filers type company names and meeting dates themselves; this site groups spellings of the same company and folds meeting dates up to three days apart. Data runs through 23 Sep 2026; the median compares 3,799 companies.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Merck & Co., Inc., grouped by company. The name is the most common spelling among filers; the ticker and SEC company number come from the SEC company tickers file, matched on the exact name. Not verified by the SEC. Filings read through 23 Sep 2026; page built 26 Sep 2026.